Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Koong

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 28, 2003
Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinomaQuynh-Thu Le, David Tate, Albert Koong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2013
A novel aldehyde dehydrogenase-3 activator (Alda-89) protects submandibular gland function from irradiation without accelerating tumor growthNan Xiao, Hongbin Cao, Che-Hong Chen, et al.
Cancer|March 15, 2006
Mature results from a randomized Phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomasQuynh-Thu Le, Al Taira, Sherie Budenz, et al.
Annals of Surgical Oncology|November 15, 2012
Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement?Manali I Patel, Kim F Rhoads, Yifei Ma, et al.
Advances in Radiation Oncology|March 9, 2021
Effectively Conducting Oncology Clinical Trials During the COVID-19 PandemicDebra Nana Yeboa, Chidinma Anakwenze Akinfenwa, Jonathan Nguyen, et al.
Cancer Research|June 3, 2006
Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasisNadja Dornhöfer, Suzanne Spong, Kevin Bennewith, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2009
Impaired interferon signaling is a common immune defect in human cancerRebecca J Critchley-Thorne, Diana L Simons, Ning Yan, et al.
Advances in Radiation Oncology|March 29, 2024
Long-Term Patient-Reported Dyspareunia After Definitive Chemoradiation for Anal Cancer: Using the Anterior Vaginal Wall as an Organ-at-Risk to Define an Actionable Dosimetric GoalMichael K Rooney, Joshua S Niedzielski, Ramon M Salazar, et al.
Clinical Colorectal Cancer|March 17, 2020
Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal AdenocarcinomaSantiago Avila, George J Chang, N Arvind Dasari, et al.
Practical Radiation Oncology|June 1, 2022
Patient-Reported Sexual Function in Long-Term Survivors of Anal Cancer Treated With Definitive Intensity Modulated Radiation Therapy and Concurrent ChemotherapyKelsey L Corrigan, Michael K Rooney, Brian De, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
International Journal of Radiation Oncology, Biology, Physics|June 28, 2003
Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinomaQuynh-Thu Le, David Tate, Albert Koong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2013
A novel aldehyde dehydrogenase-3 activator (Alda-89) protects submandibular gland function from irradiation without accelerating tumor growthNan Xiao, Hongbin Cao, Che-Hong Chen, et al.
Cancer|March 15, 2006
Mature results from a randomized Phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomasQuynh-Thu Le, Al Taira, Sherie Budenz, et al.
Annals of Surgical Oncology|November 15, 2012
Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement?Manali I Patel, Kim F Rhoads, Yifei Ma, et al.
Advances in Radiation Oncology|March 9, 2021
Effectively Conducting Oncology Clinical Trials During the COVID-19 PandemicDebra Nana Yeboa, Chidinma Anakwenze Akinfenwa, Jonathan Nguyen, et al.
Cancer Research|June 3, 2006
Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasisNadja Dornhöfer, Suzanne Spong, Kevin Bennewith, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2009
Impaired interferon signaling is a common immune defect in human cancerRebecca J Critchley-Thorne, Diana L Simons, Ning Yan, et al.
Advances in Radiation Oncology|March 29, 2024
Long-Term Patient-Reported Dyspareunia After Definitive Chemoradiation for Anal Cancer: Using the Anterior Vaginal Wall as an Organ-at-Risk to Define an Actionable Dosimetric GoalMichael K Rooney, Joshua S Niedzielski, Ramon M Salazar, et al.
Clinical Colorectal Cancer|March 17, 2020
Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal AdenocarcinomaSantiago Avila, George J Chang, N Arvind Dasari, et al.
Practical Radiation Oncology|June 1, 2022
Patient-Reported Sexual Function in Long-Term Survivors of Anal Cancer Treated With Definitive Intensity Modulated Radiation Therapy and Concurrent ChemotherapyKelsey L Corrigan, Michael K Rooney, Brian De, et al.
Pageof 5